177 related articles for article (PubMed ID: 11046139)
21. Novel Cdk inhibitors restore TGF-beta sensitivity in cdk4 overexpressing epithelial cells.
Soni R; Fretz H; Muller L; Schoepfer J; Chaudhuri B
Biochem Biophys Res Commun; 2000 Jun; 272(3):794-800. PubMed ID: 10860833
[TBL] [Abstract][Full Text] [Related]
22. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; Catricalà C; O'Toole KM
Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
[TBL] [Abstract][Full Text] [Related]
23. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
Cancer Res; 1997 May; 57(9):1638-43. PubMed ID: 9134999
[TBL] [Abstract][Full Text] [Related]
24. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
[TBL] [Abstract][Full Text] [Related]
26. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity.
Wang J; Sergina N; Ko TC; Gong J; Brattain MG
J Biol Chem; 2004 Sep; 279(38):40237-44. PubMed ID: 15271980
[TBL] [Abstract][Full Text] [Related]
27. Roles of cyclin-dependent kinase 4 and p53 in neuronal cell death induced by doxorubicin on cerebellar granule neurons in mouse.
Otsuka Y; Tanaka T; Uchida D; Noguchi Y; Saeki N; Saito Y; Tatsuno I
Neurosci Lett; 2004 Jul; 365(3):180-5. PubMed ID: 15246544
[TBL] [Abstract][Full Text] [Related]
28. G1 kinases and transforming growth factor-beta signaling are associated with a growth pattern switch in diabetes-induced renal growth.
Huang HC; Preisig PA
Kidney Int; 2000 Jul; 58(1):162-72. PubMed ID: 10886561
[TBL] [Abstract][Full Text] [Related]
29. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
Ando K; Griffin JD
Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
[TBL] [Abstract][Full Text] [Related]
30. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
[TBL] [Abstract][Full Text] [Related]
31. An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4.
Li J; Joo SH; Tsai MD
Biochemistry; 2003 Nov; 42(46):13476-83. PubMed ID: 14621993
[TBL] [Abstract][Full Text] [Related]
32. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein.
Herrera RE; Mäkelä TP; Weinberg RA
Mol Biol Cell; 1996 Sep; 7(9):1335-42. PubMed ID: 8885230
[TBL] [Abstract][Full Text] [Related]
33. The identification of an internal ribosomal entry site in the 5'-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage.
Yang DQ; Halaby MJ; Zhang Y
Oncogene; 2006 Aug; 25(33):4613-9. PubMed ID: 16607284
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of p27 and cyclin D1 by TGF-beta and EGF in C3H 10T1/2 mouse fibroblasts.
Ravitz MJ; Yan S; Dolce C; Kinniburgh AJ; Wenner CE
J Cell Physiol; 1996 Sep; 168(3):510-20. PubMed ID: 8816905
[TBL] [Abstract][Full Text] [Related]
35. p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness.
Wolfraim LA; Walz TM; James Z; Fernandez T; Letterio JJ
J Immunol; 2004 Sep; 173(5):3093-102. PubMed ID: 15322169
[TBL] [Abstract][Full Text] [Related]
36. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
Iavarone A; Massagué J
Nature; 1997 May; 387(6631):417-22. PubMed ID: 9163429
[TBL] [Abstract][Full Text] [Related]
37. Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
AbuHammad S; Cullinane C; Martin C; Bacolas Z; Ward T; Chen H; Slater A; Ardley K; Kirby L; Chan KT; Brajanovski N; Smith LK; Rao AD; Lelliott EJ; Kleinschmidt M; Vergara IA; Papenfuss AT; Lau P; Ghosh P; Haupt S; Haupt Y; Sanij E; Poortinga G; Pearson RB; Falk H; Curtis DJ; Stupple P; Devlin M; Street I; Davies MA; McArthur GA; Sheppard KE
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17990-18000. PubMed ID: 31439820
[TBL] [Abstract][Full Text] [Related]
38. Modifications of p53 protein and accumulation of p21 and gadd45 mRNA in TGF-beta 1 growth inhibited cells.
Landesman Y; Bringold F; Milne DD; Meek DW
Cell Signal; 1997; 9(3-4):291-8. PubMed ID: 9218130
[TBL] [Abstract][Full Text] [Related]
39. Building p53.
Terzian T; Lozano G
Genes Dev; 2010 Oct; 24(20):2229-32. PubMed ID: 20952532
[TBL] [Abstract][Full Text] [Related]
40. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.
Sotillo R; Dubus P; Martín J; de la Cueva E; Ortega S; Malumbres M; Barbacid M
EMBO J; 2001 Dec; 20(23):6637-47. PubMed ID: 11726500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
